Medical research

ClinicalConnection.com Launches PATIENTSelect™ for Direct Marketing and Patient Engagement

Retrieved on: 
Tuesday, September 24, 2019

PATIENTSelect enables third parties to leverage ClinicalConnection's online community of more than 650,000 members for a wide variety of initiatives such as Direct to Patient Advertising , patient education, surveys, focus groups and patient recruitment.

Key Points: 
  • PATIENTSelect enables third parties to leverage ClinicalConnection's online community of more than 650,000 members for a wide variety of initiatives such as Direct to Patient Advertising , patient education, surveys, focus groups and patient recruitment.
  • As a leader amongst digital clinical trial recruitment companies , ClinicalConnection.com has been providing patient outreach and engagement services to the pharmaceutical industry for more than two decades.
  • Companies and clinical trial centers can list clinical trials on ClinicalConnection's searchable website and send targeted trial notifications to relevant members.
  • ClinicalConnection.com has listed over 40,000 clinical trials and sent more than one million referrals to clinical research studies.

Oracle Survey Finds Investigative Sites Still Frustrated with eClinical Technology

Retrieved on: 
Tuesday, September 24, 2019

The survey Impact Assessment of eClinical Technologies and Industry Initiatives on Sites commissioned by Oracle Health Sciences and conducted by the Society for Clinical Research Sites (SCRS) reveals a downward trend in site satisfaction with the current eClinical environment when participating in clinical trials.

Key Points: 
  • The survey Impact Assessment of eClinical Technologies and Industry Initiatives on Sites commissioned by Oracle Health Sciences and conducted by the Society for Clinical Research Sites (SCRS) reveals a downward trend in site satisfaction with the current eClinical environment when participating in clinical trials.
  • The survey indicates that while innovation in both clinical trial design and technology meant to improve the site and patient experience is available, investigative sites are concerned about the additional burden these technology changes bring in terms of training, complicated login processes, data duplication, etc.
  • Sponsors and technology vendors can help by simplifying the technology environment in which sites must work to participate in clinical research."
  • The survey was conducted by the Society for Clinical Research Sites (SCRS) and sponsored by Oracle Health Sciences and ran from late April 2019 into June 2019.

OCT Clinical Trials Appoints Maxime Stevens as Chief Strategy and Development Officer; Poises for Global Expansion

Retrieved on: 
Monday, September 23, 2019

SAINT PETERSBURG, Russia, Sept. 23, 2019 /PRNewswire-PRWeb/ -- OCT Clinical Trials , a leading CRO with operations in Eastern Europe, today announced that it has appointed Maxime Stevens as Chief Strategy and Development Officer.

Key Points: 
  • SAINT PETERSBURG, Russia, Sept. 23, 2019 /PRNewswire-PRWeb/ -- OCT Clinical Trials , a leading CRO with operations in Eastern Europe, today announced that it has appointed Maxime Stevens as Chief Strategy and Development Officer.
  • "It is both an honor and pleasure for me to be joining OCT Clinical Trials as their Chief Strategy and Development Officer," Stevens said.
  • Her extensive international experience, most notably in MENA, Africa, Europe and the United States, is a valuable asset for OCT Clinical Trials as the company moves toward global expansion.
  • Since 2005, OCT Clinical Trials has worked on over 300 full-service and functional service projects in more than 20 therapeutic areas.

Practical Implementation of GCP in Veterinary Field Studies (London, United Kingdom - April 29-30, 2020)

Retrieved on: 
Thursday, September 19, 2019

DUBLIN, Sept. 19, 2019 /PRNewswire/ -- The "Practical Implementation of GCP in Veterinary Field Studies" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 19, 2019 /PRNewswire/ -- The "Practical Implementation of GCP in Veterinary Field Studies" conference has been added to ResearchAndMarkets.com's offering.
  • This seminar will take many aspects of animal health and veterinary research and development through a typical clinical trial, and pay attention to compliance with Good Clinical Practice (GCP) as outlined in the two guidelines on safety and efficacy produced by FEDESA and the CVMP.
  • The course will address a typical case study where a practical approach will be made to setting up, running and monitoring clinical trials followed by an audit of these studies to satisfy the stringent requirements seen in Europe.
  • Standard documentation utilised for recording data, performing audits and a typical protocol will be supplied for use in the company attendees' own laboratories.

George Clinical Grows European Presence with New Location in the United Kingdom

Retrieved on: 
Thursday, September 19, 2019

LONDON, Sept. 19, 2019 /PRNewswire/ --George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.

Key Points: 
  • LONDON, Sept. 19, 2019 /PRNewswire/ --George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.
  • "Our new London office includes space for our growing U.K.-based staff to work together in one location," said Joanna Cole, Senior Business and Finance Manager for George Clinical.
  • The Clinical Research Network is part of this organization and provides reliable infrastructure to support clinical research in the UK and the European Union.
  • George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence.

2-Day Seminar: Practical Implementation of GCP in Veterinary Field Studies (London, United Kingdom - April 29-30, 2020) - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 19, 2019

The "Practical Implementation of GCP in Veterinary Field Studies" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Practical Implementation of GCP in Veterinary Field Studies" conference has been added to ResearchAndMarkets.com's offering.
  • This seminar will take many aspects of animal health and veterinary research and development through a typical clinical trial, and pay attention to compliance with Good Clinical Practice (GCP) as outlined in the two guidelines on safety and efficacy produced by FEDESA and the CVMP.
  • The course will address a typical case study where a practical approach will be made to setting up, running and monitoring clinical trials followed by an audit of these studies to satisfy the stringent requirements seen in Europe.
  • Standard documentation utilised for recording data, performing audits and a typical protocol will be supplied for use in the company attendees' own laboratories.

IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study

Retrieved on: 
Thursday, September 19, 2019

Our product Hyalolex, modeled after IGC-AD1 and currently available in more than 40 dispensaries in Puerto Rico is based on this research.

Key Points: 
  • Our product Hyalolex, modeled after IGC-AD1 and currently available in more than 40 dispensaries in Puerto Rico is based on this research.
  • Regarding the IRB approval for a Phase-2 study, Mr. Mukunda added, Our Company will now prepare and file an Investigational New Drug Application (INDA) with the FDA in support of the protocol.
  • The University of Puerto Rico Medical Sciences Campus maintains IRB panels that is responsible for approving research protocols on human subjects.
  • IGC has two lines of business: i) infrastructure and ii) plant and cannabinoid-based products.

The Conference Forum Announces Tasso Wins DPharm Idol Disrupt 2019 for Patient-Centric Blood Sampling Kits

Retrieved on: 
Wednesday, September 18, 2019

BOSTON, Sept. 18, 2019 /PRNewswire-PRWeb/ -- Tasso was announced the winner of DPharm Idol Disrupt at the 9th annual DPharm: Disrupting Innovations to Advance Clinical Trials Conference.

Key Points: 
  • BOSTON, Sept. 18, 2019 /PRNewswire-PRWeb/ -- Tasso was announced the winner of DPharm Idol Disrupt at the 9th annual DPharm: Disrupting Innovations to Advance Clinical Trials Conference.
  • Tasso has a service that provides patient centric blood-sampling kits for use by participants in clinical trials.
  • Tasso's goal is to eliminate the need for site visits, and to lower the costs and inconvenience associated with traditional blood sampling methods.
  • Tasso aims to provide a clinical trial participant a ready made kit for blood sampling with easy to understand instructions for at-home self blood sampling, much of the patient burden for gathering blood data is eliminated.

eClinical Solutions' Dawn Kaminski Serves as Co-Chair again for SCDM 2019

Retrieved on: 
Wednesday, September 18, 2019

BOSTON, Sept. 18, 2019 /PRNewswire-PRWeb/ -- As leaders in the clinical data management industry, eClinical Solutions team members were selected to participate in SCDM 2019 as the co-chair, session leaders and expert speakers.

Key Points: 
  • BOSTON, Sept. 18, 2019 /PRNewswire-PRWeb/ -- As leaders in the clinical data management industry, eClinical Solutions team members were selected to participate in SCDM 2019 as the co-chair, session leaders and expert speakers.
  • The 2019 SCDM Annual Meeting will take place in Baltimore, Maryland from September 29 to October 2.
  • "Data management is core to our business, which is why SCDM is so important to us," says Katrina Rice, eClinical Solutions' Executive Vice President of Professional Services.
  • "It is essential to give the life sciences industry the right tools for accurate and timely data review and management.

Anju Completes Merger With OmniComm Systems

Retrieved on: 
Wednesday, September 18, 2019

FORT LAUDERDALE, Fla., Sept. 18, 2019 (GLOBE NEWSWIRE) -- OmniComm Systems Inc. announced today that Anju Software Inc. has completed the acquisition of OmniComm Systems, Inc. (OTCQX: OMCM), a leading strategic software solutions provider to the life sciences industry.

Key Points: 
  • FORT LAUDERDALE, Fla., Sept. 18, 2019 (GLOBE NEWSWIRE) -- OmniComm Systems Inc. announced today that Anju Software Inc. has completed the acquisition of OmniComm Systems, Inc. (OTCQX: OMCM), a leading strategic software solutions provider to the life sciences industry.
  • The merger of OmniComm and Anju positions the combined organization as a leader in the eClinical solutions market, with particular expertise in electronic data capture and eSource.
  • Anju is able to immediately add CTMS, eTMF, data migration and integration tools and dynamic reporting, integrated with the existing solutions, to the OmniComm suite of eClinical solutions.
  • I am glad that two years of discussions with OmniComm has culminated in the acquisition of OmniComm by Anju.